Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes.

Diabetologia
J LinG C Curhan

Abstract

Potentially modifiable biomarkers may influence the decline in estimated GFR (eGFR), but few data are currently available in type 2 diabetic adults. We studied 516 women with type 2 diabetes in the Nurses' Health Study with data on lipid and inflammatory biomarkers from plasma collected in 1989 and plasma creatinine in samples collected in 1989 and 2000. An estimated GFR decline of >or=25% over 11 years was the outcome of interest. Comparing the highest with the lowest quartile, soluble tumour necrosis factor receptor 2 (sTNFR-2) was independently associated with an eGFR decline of >or=25% (multivariate OR 5.81; 95% CI 2.90-11.65); this association was stronger in obese women (OR 16.76; 95% CI 4.69-59.90 for BMI >or=30 kg/m(2); OR 2.78, 95% CI 1.12-6.89 for BMI <30 kg/m(2); p for interaction = 0.02). No lipids (total cholesterol, LDL-cholesterol, HDL-cholesterol, non-HDL-cholesterol, triacylglycerols, lipoprotein(a), or apolipoprotein B) or other markers of inflammation (C-reactive protein, fibrinogen, E-selectin, intracellular cell adhesion molecule 1, leptin or adiponectin) were significantly associated with eGFR decline after multivariable adjustment. Elevated sTNFR-2 levels may be an important and potentially modifiable ris...Continue Reading

References

Jul 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K A Nath
Dec 8, 2004·Journal of the American Society of Nephrology : JASN·Linda FriedAnne Newman
Jun 16, 2005·Kidney International·Marcello TonelliUNKNOWN Cholesterol and Recurrent Events (CARE) Trial Investigators
May 30, 2006·Diabetes·Ravi RetnakaranUNKNOWN UKPDS Study Group
Jun 9, 2006·The New England Journal of Medicine·Lesley A StevensAndrew S Levey
Jun 26, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Tao YangGlenda C Gobe
Aug 7, 2007·The American Journal of Medicine·Aruna D PradhanPaul M Ridker
Apr 10, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Julie Lin, Gary C Curhan
Apr 29, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Meredith C FosterCaroline S Fox

❮ Previous
Next ❯

Citations

Jul 26, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ko HanaiYasuhiko Iwamoto
Jan 24, 2012·Journal of the American Society of Nephrology : JASN·Monika A NiewczasAndrzej S Krolewski
Aug 13, 2010·The American Journal of Clinical Nutrition·Julie LinWilliam McClellan
May 10, 2013·Current Diabetes Reports·Tomohito Gohda, Yasuhiko Tomino
Feb 4, 2011·Diabetes Research and Clinical Practice·Itsuko MiyazawaHiroshi Maegawa
Mar 11, 2015·Current Hypertension Reports·Divya HariharanHolly Kramer
Apr 12, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Hsin-Fang ChungMeng-Chuan Huang
Jan 15, 2015·Journal of Diabetes Research·I-Th LampropoulouG Efstratiadis
Nov 8, 2016·Advances in Medicine·Mohammad Hossein RouhaniLeila Azadbakht
May 31, 2018·Postgraduate Medicine·Angelika BazylukEdyta Zbroch
Feb 6, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Jørgen ScheiToralf Melsom
May 4, 2011·Nature Reviews. Nephrology·Juan F Navarro-GonzálezJavier García-Pérez
Jun 18, 2019·Diabetes/metabolism Research and Reviews·Xiaoqi YeJinbo Hu
Mar 1, 2017·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Matthew W WongPerminder S Sachdev
Aug 2, 2017·Clinical Science·Greg H Tesch
Apr 25, 2020·Journal of Nephrology·Giuseppina RussoSalvatore De Cosmo
Jul 21, 2021·Scientific Reports·Oyunchimeg BuyadaaJonathan E Shaw

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.